Stock Watch: The Cost And Risks Of Pharmaceutical Success
EHA Was Uncomfortable Platform For Gilead And IN8bio
Presenting at conferences allows companies to showcase data on new drugs and secure licensing partners, as well as further investment by shareholders. But two presentations at the recent EHA conference had the opposite effect.